Biocon Limited (NSE:BIOCON)
India
· Delayed Price · Currency is INR 325.75
-9.95 (-2.96%)
Apr 24, 2025, 3:30 PM IST
Biocon Employees
Biocon had 16,315 employees as of March 31, 2024. The number of employees decreased by 230 or -1.39% compared to the previous year.
Employees
16,315
Change (1Y)
-230
Growth (1Y)
-1.39%
Revenue / Employee
9.05M INR
Profits / Employee
492.98K INR
Market Cap
391.06B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 9,741 |
| Cipla | 27,764 |
| Mankind Pharma | 19,540 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 26,921 |
| Aurobindo Pharma | 26,015 |
| Alkem Laboratories | 17,432 |
Biocon News
- 22 hours ago - Biocon to raise Rs 4,500 crore via QIP or other routes - Business Upturn
- 1 day ago - Eris Lifesciences, Lupin and Biocon shares in focus as Novo Nordisk exits Rs 800 crore Human Mixtard brand, says report - Business Upturn
- 4 days ago - Biocon shares in focus ahead of April 23 board meeting to consider fundraise proposal - Business Upturn
- 9 days ago - Biocon shares jump 3% as its subsidiary secures US market entry for Yesafili - Business Upturn
- 9 days ago - Biocon Biologics secures U.S. market entry for Yesafili™, an interchangeable biosimilar to Eylea® - Business Upturn
- 13 days ago - Biocon shares rise over 3% as USFDA approves bevacizumab biosimilar Jobevne™ for cancer treatment - Business Upturn
- 13 days ago - Top stocks to watch today, April 11: Tata Steel, Infosys, TCS, BHEL, Aurobindo Pharma, Biocon and more - Business Upturn
- 14 days ago - Biocon Biologics receives U.S. FDA approval for bevacizumab biosimilar JOBEVNE - Business Upturn